1. Giovenco D, Pettifor A, Powers KA, Hightow-Weidman L, et al.
   Intimate partner violence and oral HIV pre-exposure prophylaxis adherence among young African women.
   AIDS 2022.
   


2. Shrestha I, Ming K, Jimenez V, Wendelborn J, et al.
   Lessons learned from an HIV pre-exposure prophylaxis coordination program in San Francisco primary care clinics.
   AIDS Res Hum Retroviruses 2022.
   


3. De Schacht C, Lucas C, Paulo P, Van Rompaey S, et al.
   Reaching males and young adults in a pharmacy-based HIV self-testing strategy: Results from an acceptability study in Mozambique.
   AIDS Res Hum Retroviruses 2022.
   


4. Malama K, Logie CH, Narasimhan M, Ouedraogo L, et al.
   Short Communication vertical line Awareness of HIV self-care interventions across global regions: results from a values and preferences survey.
   AIDS Res Hum Retroviruses 2022.
   


5. Saberi P, Campbell C, Sauceda JA, Ndukwe SO, et al.
   Perceptions of risks and benefits of participating in HIV cure-related research among diverse young adults living with HIV in the United States: qualitative research findings.
   AIDS Res Hum Retroviruses 2022.
   


6. Fuller D, O'Connor MA.
   Letter to the Editor on Guerriero et al.: Prior infection with coccidioidomycosis in nonhuman primates and impact on SIV disease and vaccine immunogenicity.
   AIDS Res Hum Retroviruses 2022.
   


7. Tashiro Y, Matsuura E, Sagara Y, Nozuma S, et al.
   High Prevalence of HTLV-1 Carriers Among the Elderly Population in Kagoshima, a Highly Endemic Area in Japan.
   AIDS Res Hum Retroviruses 2022;38:363-369.
   


8. Tordoff DM, Dombrowski JC, Ramchandani MS, Barbee LA, et al.
   Trans-inclusive Sexual Health Questionnaire to Improve HIV/STI Care for Transgender Patients: Anatomic-site Specific STI Prevalence & Screening Rates.
   Clin Infect Dis 2022.
   


9. Kamau E, Chaudhury S, Bolton JS, Slike BM, et al.
   Susceptibility to HIV-1 Acquisition linked to Malaria Exposure: A Case-control Study.
   Clin Infect Dis 2022.
   


10. Cox H, Workman L, Bateman L, Franckling-Smith Z, et al.
    Oral swabs tested with Xpert MTB/RIF Ultra for diagnosis of pulmonary tuberculosis in children: a diagnostic accuracy study.
    Clin Infect Dis 2022.
    


11. Jawa R, Walley AY, Wilson DJ, Green TC, et al.
    Prescribe to Save Lives: Improving buprenorphine prescribing among HIV clinicians.
    J Acquir Immune Defic Syndr 2022.
    


12. Jones DL, Zhang Y, Rodriguez VJ, Haberlen S, et al.
    Association of PTSD with Longitudinal COVID-19 Burden in a Mixed-Serostatus Cohort of Men and Women: Weathering the Storm.
    J Acquir Immune Defic Syndr 2022.
    


13. Garner BR, Burrus O, Ortiz A, Tueller SJ, et al.
    A longitudinal mixed-methods examination of Positive Health Check: Implementation results from a type 1 effectiveness-implementation hybrid trial.
    J Acquir Immune Defic Syndr 2022.
    


14. Hill BJ, Motley DN, Rosentel K, VandeVusse A, et al.
    Employment as HIV prevention: An employment support intervention for adolescent men who have sex with men and adolescent transgender women of color.
    J Acquir Immune Defic Syndr 2022.
    


15. Balle C, Armistead B, Kiravu A, Song X, et al.
    Factors influencing maternal microchimerism throughout infancy and its impact on infant T cell immunity.
    J Clin Invest 2022.
    


16. Chu FL, Li C, Chen L, Dong B, et al.
    Respiratory viruses among pediatric inpatients with acute lower respiratory tract infections in Jinan, China, 2016-2019.
    J Med Virol 2022.
    


17. Cai S, Liao G, Yu T, Gao Q, et al.
    Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine in people living with HIV: A cross-sectional study.
    J Med Virol 2022.
    


18. Malonga GA, Dienta S, Traore FT, Maiga Z, et al.
    Human Herpesvirus 8 seroprevalence among blood donors in Mali.
    J Med Virol 2022.
    


19. Pei Z, Wang H, Zhao Z, Chen X, et al.
    Chemokine PF4 Inhibits EV71 and CA16 Infections at the Entry Stage.
    J Virol 2022.
    


20. Watts G.
    Luc Antoine Montagnier.
    Lancet 2022;399:1862.
    


21. Julg B, Stephenson KE, Wagh K, Tan SC, et al.
    Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial.
    Nat Med 2022.
    

Display articles in

• Abstract format
• Medline format